BTIG analyst Ryan Zimmerman maintained a Hold rating on Integra Lifesciences (IART – Research Report) today. The company’s shares closed today ...

Analyst Craig Bijou of Bank of America Securities reiterated a Sell rating on Integra Lifesciences (IART – Research Report), with a price ...

Advanced wound dressings (for example, alginate, film, foam, hydrocolloid and hydrogel dressings) regulate the wound surface by retaining moisture or absorbing exudate, so protecting the wound base ...

It aims to provide an in-depth understanding of the current market scenario and the impact of COVID-19 on the industry. On average, there are 450,000 burn injuries throughout the United States each ...

Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.

IART currently has a forward P/E ratio of 9.26, while PEN has a forward P/E of 62.66. We also note that IART has a PEG ratio of 0.77. This popular figure is similar to the widely-used P/E ratio, but ...

The U.S. stock market staged a comeback on Friday, marking a sharp rebound after a subdued start to the new year. Investors ended the holiday-shortened week with optimism bolstered by expectations of ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Investors in Integra LifeSciences Holdings Corporation IART need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $5 Callhad some of ...

Integra LifeSciences Holdings said a subsidiary received a warning letter from the Food and Drug Administration over issues identified during inspections at three company facilities.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The global chronic wound care market is poised for significant growth, with a projected rise at a Compound Annual Growth Rate (CAGR) of 3.8% from 2023 to 2033. The market value is forecasted to ...